Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Share-based Compensation (2020 - 2025)

Sight Sciences has reported Share-based Compensation over the past 6 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.5 million for Q4 2025, down 77.6% from a year ago — trailing twelve months through Dec 2025 was $13.1 million (down 33.04% YoY), and the annual figure for FY2025 was $13.1 million, down 23.56%.
  • Share-based Compensation for Q4 2025 was $2.5 million at Sight Sciences, up from $2.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for SGHT hit a ceiling of $11.4 million in Q4 2024 and a floor of -$2.6 million in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $2.4 million (2023), compared with a mean of $2.7 million.
  • Biggest five-year swings in Share-based Compensation: surged 1284.62% in 2021 and later plummeted 181.05% in 2023.
  • Sight Sciences' Share-based Compensation stood at $2.0 million in 2021, then skyrocketed by 63.66% to $3.2 million in 2022, then plummeted by 181.05% to -$2.6 million in 2023, then skyrocketed by 534.07% to $11.4 million in 2024, then plummeted by 77.6% to $2.5 million in 2025.
  • The last three reported values for Share-based Compensation were $2.5 million (Q4 2025), $2.4 million (Q3 2025), and $3.8 million (Q2 2025) per Business Quant data.